The trademark application KyNexis was filed by KyNexis B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on February 14, 2023, and it was registered by office on May 24, 2023 without any oppositions.
It was designated 'Basic Application' for International Application 1739938 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Partial Surrender of the trademark registration was recorded on August 8, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical products
Biological preparations for use in medical therapy, clinical medical reagents, gene diagnosis and gene testing
Pharmaceutical preparations, prophylaxis products and other pharmaceutical products.
The mark was filed in class 42 with Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry and Research and product development in the field of pharmaceutics..
The mark was filed in class 44 with modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders and Consultancy in the field of pharmaceutics..